FDA Approves Novel Eye Drop for Age-Related Near Vision Loss

The U.S. Food and Drug Administration has approved phentolamine ophthalmic solution 0.75% (Ryzumvi) by Viatris for treating presbyopia in adults. This decision introduces a new once-nightly eye drop option for individuals experiencing age-related near vision loss, offering an additional therapeutic choice for a common condition affecting many adults.